Wolverine Trading’s Filana Therapeutics FLNA Stock Holding History

Wolverine Trading’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-18,733	Closed	-$431K	–	5316
2024 Q2	$231K	Sell	18,733 -7,860	-30%	-$166K	﹤0.01%	3694
2024 Q1	$540K	Buy	+26,593	New	+$613K	﹤0.01%	2764
2023 Q3	–	Sell	-17,987	Closed	-$356K	–	5014
2023 Q2	$426K	Buy	17,987 +8,127	+82%	+$196K	﹤0.01%	2766
2023 Q1	$237K	Buy	+9,860	New	+$273K	﹤0.01%	3263
2022 Q1	–	Sell	-21,906	Closed	-$928K	–	6317
2021 Q4	$959K	Sell	21,906 -10,715	-33%	-$562K	﹤0.01%	2661
2021 Q3	$2.03M	Buy	32,621 +15,232	+88%	+$1.27M	﹤0.01%	2139
2021 Q2	$1.44M	Buy	17,389 +3,320	+24%	+$178K	﹤0.01%	2351
2021 Q1	$618K	Buy	+14,069	New	+$553K	﹤0.01%	3416
2016 Q4	–	Sell	-1,648	Closed	-$12K	–	5030
2016 Q3	$12K	Buy	+1,648	New	+$27.3K	﹤0.01%	4530

Other funds holding FLNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Wolverine Trading's FLNA Position: Q3 2024 in Review

Wolverine Trading sold out of Filana Therapeutics (FLNA) in Q3 2024, closing a stake of 18,733 shares — an estimated $431K sold.

Wolverine Trading first reported a position in FLNA in Q3 2016 and held it in 9 quarters. The position peaked at $2.03M in Q3 2021. 161 funds tracked by Wall St. Rank hold FLNA as of Q3 2024.

Wolverine Trading reported no remaining Filana Therapeutics position as of Q3 2024 after selling out during the quarter.
Wolverine Trading sold 18,733 Filana Therapeutics shares in Q3 2024, an estimated $431K.
Wolverine Trading first reported a position in Filana Therapeutics in Q3 2016 and held it in 9 quarters.
Wolverine Trading's Filana Therapeutics position peaked at $2.03M in Q3 2021.
161 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2024.

Based on Wolverine Trading's 13F filing for Q3 2024, filed 14 Nov 2024.